A short introduction to papillomavirus biology

Intervirology

Volumn 45, Issue 4-6, 2002, Pages 287-289

  Streeck, Rolf E ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Inst F Med Mikrobiol und Hygiene   (Germany)

Author keywords

Capsid proteins; Cervical carcinoma; Human papillomavirus; Immortalization; Neutralization; Papillomavirus; POD; Pseudovirion; Receptor; Virus like particles

Indexed keywords

VIRUS PROTEIN;

CONFERENCE PAPER; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRION; VIROGENESIS; VIRUS IMMUNITY;

HUMANS; PAPILLOMAVIRIDAE; RECEPTORS, VIRUS; VIRAL PROTEINS; VIRION;

HUMAN PAPILLOMAVIRUS; MIRIDAE; PAPILLOMAVIRUS;

EID: 0036980094     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067920     Document Type: Conference Paper

References (18)

1. Knipe DM, Howley PM (eds): Fields' Virology, ed 4. Baltimore, Lippincott Williams & Wilkins, 2001.
2. Dillner J, Kallings I, Brihmer C, Sikström B, Koskela P, Lehtinen M, Schiller JT, Sapp M, Mårdt PA: Seropositivity to human papillomavirus types 16, 18 or 33 capsids and to Chlamydia trachomatisare markers of sexual behavior. J Infect Dis 1996;173:1394-1398.
3. Koutsky L: Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
4. Sapp M, Fligge C, Petzak I, Harris JR, Streeck RE: Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J Virol 1998;72:6186-6189.
5. Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol 1993;67:315-322.
6. Fligge C, Schäfer F, Selinka H-C, Sapp C, Sapp M: DNA-induced structural changes in the papillomavirus capsid. J Virol 2001;75:7727-7731.
7. Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC: Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 2000;5:557-567.
8. Unckell F, Streeck RE, Sapp M: Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol 1997;71:2934-2939.
9. Kawana Y, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T: Human papillomavirus type 16 minor capsid protein 12 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J Virol 2001;75:2331-2336.
10. Day PM, Roden RBS, Lowy RL, Schiller JT: The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol 1998;72:142-150.
11. Florin L, Schäfer F, Sotlar K, Streeck RE, Sapp M: Reorganization of nuclear domain 10 induced by papillomavirus capsid protein L2. Virology 2002;295:97-107.
12. Volpers C, Unckell F, Schirmacher P, Streeck RE, Sapp M: Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol 1995;69:3258-3264.
13. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM: The L1 major capsid protein of human papillomavirus 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 1999;274:5810-5822.
14. Giroglou T, Florin L, Schäfer F, Streeck RE, Sapp M: Human papillomavirus infection requires cell surface heparan sulfate. J Virol 2001;75:1565-1570.
15. Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, Schiller JT, Lowy DR: Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995;69:3959-3963.
16. Giroglou T, Sapp M, Lane L, Fligge C, Christensen ND, Streeck RE, Rose RC: Immunological analyses of human papillomavirus capsids. Vaccine 2001;19:1783-1793.
17. Roden RBS, Weissinger EM, Henderson DW, Booy F, Kirnbauer R, Mushinski JF, Lowy DR, Schiller JT: Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol 1994;68:7570-7574.
18. Greenstone HL, Nieland JD, de Visser KE, de Bruijn ML, Kirnbauer R, Roden RBS, Lowy DR, Kast WM, Schiller JT: Chimeric papilloma virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc Natl Acad Sci USA 1998;95:1800-1805.